A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer

被引：0
|
作者：
Heather Wakelee
George A. Fisher
机构：
[1] Stanford Clinical Cancer Center,
来源：
Investigational New Drugs | 2005年 / 23卷
关键词：
amifostine; irinotecan; phase I; colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 242
页数：1
相关论文
共 50 条
  • [31] Irinotecan Hydrochloride (CPT-11) in Dialysis Patients with Gastrointestinal Cancer
    Ashizawa, Tatsuto
    Iwahori, Tohru
    Yokoyama, Takayoshi
    Kihara, Yuu
    Konnno, Osamu
    Jyojima, Yoshimaro
    Akashi, Isao
    Nakamura, Yuuki
    Hama, Kouichirou
    Iwamoto, Hitoshi
    Segawa, Mai
    Takeuchi, Hironori
    Hirano, Toshihiko
    Nagao, Takeshi
    ACTA MEDICA OKAYAMA, 2010, 64 (01) : 19 - 26
  • [32] Phase I clinical study of irinotecan (CPT-11) in combination with UFT/folinic acid (FA) in patients with advanced colorectal cancer (CRC).
    Paz-Ares, L
    Garcia-Alfonso, P
    Castellanos, D
    Martin, B
    Perez-Manga, G
    Cortes-Funes, H
    Gonzalez, J
    Gravalos, C
    CLINICAL CANCER RESEARCH, 2000, 6 : 4575S - 4575S
  • [33] Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma
    Baudin, E
    Docao, C
    Gicquel, C
    Vassal, G
    Bachelot, A
    Penfornis, A
    Schlumberger, M
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1806 - 1809
  • [34] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Koji Okabayashi
    Hirotoshi Hasegawa
    Yoshiyuki Ishii
    Takashi Endo
    Hiroki Ochiai
    Tetsuro Kubota
    Yuko Kitagawa
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 501 - 507
  • [35] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [36] EFFICACY OF COMBINATION CHEMOTHERAPY WITH IRINOTECAN (CPT-11) PLUS CAPECITABINE IN PATIENTS WITH METASTATIC OR ADVANCED COLORECTAL CARCINOMA
    Gennatas, C.
    Michalaki, V.
    Gennatas, S.
    Voros, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 148 - 148
  • [37] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Okabayashi, Koji
    Hasegawa, Hirotoshi
    Ishii, Yoshiyuki
    Endo, Takashi
    Ochiai, Hiroki
    Kubota, Tetsuro
    Kitagawa, Yuko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 501 - 507
  • [38] Phase II study of irinotecan (CPT-11) in patients with 5-Fluorouracil-refractory metastatic colorectal carcinoma - An Asian experience
    Ang, PCS
    Koo, WH
    Au, E
    Ang, PT
    Khoo, KS
    ANNALS OF ONCOLOGY, 1998, 9 : 45 - 45
  • [39] Phase I study of CPT-11 and bolus 5-FU/l-leucovorin in patients with metastatic colorectal cancer
    Fujishima H.
    Kikuchi I.
    Miyanaga O.
    Ueda A.
    Baba E.
    Mitsugi K.
    Harada M.
    Nakano S.
    International Journal of Clinical Oncology, 2004, 9 (2) : 92 - 97
  • [40] A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancer
    A. Sabharwal
    P. G. Corrie
    R. S. Midgley
    C. Palmer
    J. Brady
    P. Mortimer
    A. J. Watson
    G. P. Margison
    M. R. Middleton
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 829 - 835
12345